# Skincare for Skin of Color: A Dermatologist-Led Guide

> Skin of color is more prone to post-inflammatory hyperpigmentation and requires gentle actives, consistent SPF.

*Skin of color — Fitzpatrick types IV through VI — has higher baseline melanin and more reactive melanocytes, making post-inflammatory hyperpigmentation (PIH) the dominant dermatological concern. Over-aggressive exfoliation, harsh actives, and inadequate sun protection worsen PIH. The AAD identifies this as a unique dermatologic challenge.*

- Canonical: https://beautycomparison.com/skincare-for-skin-of-color
- Reviewed: 2026-06-20
- Publisher: Beauty Comparison (Beauty Comparison Editorial) — independent, brand-neutral

## Key takeaways
- Post-inflammatory hyperpigmentation (PIH) is the most clinically significant concern for skin of color — even minor inflammation from acne, ingrown hairs, or over-aggressive skincare can leave dark marks that persist for months.
- Darker skin tones have a higher natural SPF (13.4 versus 3.3 in fair skin) but this does not eliminate UV-induced pigmentation, photoaging, or skin cancer risk — daily SPF 30+ is non-negotiable for all skin tones.
- Azelaic acid (15–20%), niacinamide (5–10%), tranexamic acid, and low-concentration retinoids are the first-line evidence-backed topical agents for PIH treatment; hydroquinone is effective but requires physician supervision.
- Harsh physical scrubs, high-percentage AHAs, and aggressive exfoliation methods frequently worsen PIH in skin of color by triggering reactive melanocyte inflammation — gentle exfoliation at lower frequencies is the correct approach.
- Skin of color is represented at significantly lower rates in dermatology clinical trials, creating knowledge gaps; the specialty of dermatology has increasingly recognized this as a problem, with dedicated academic programs in skin of color dermatology.
- Iron oxide-containing tinted sunscreens provide an additional benefit for skin of color: blocking visible light (blue-violet wavelengths), which independently triggers hyperpigmentation in skin with higher melanin content.

## Understanding Skin of Color: What Makes It Distinct

"Skin of color" is a clinical and cultural term describing individuals with [Fitzpatrick](/fitzpatrick-skin-types) skin types IV through VI — encompassing people of African, South and Southeast Asian, East Asian, Hispanic/Latino, Middle Eastern, and Indigenous descent. This is not a monolithic category: the biology varies across and within ethnic groups. But shared characteristics relevant to skincare include:

- **Higher baseline melanin:** More melanin in the epidermis — primarily in the form of larger melanosomes more evenly distributed across the stratum spinosum — provides greater baseline UV absorption.
- **More reactive melanocytes:** Melanocytes in skin of color respond more robustly to inflammatory signals, UV exposure, and hormonal stimuli by producing excess melanin. This is the primary driver of PIH.
- **Stronger barrier function on average:** Darker skin types tend to have a more robust [skin barrier](/skin-barrier-repair-guide) with higher [ceramide](/ceramides-skin-barrier) content and lower TEWL — an advantage for barrier health but not immunity from barrier damage.
- **Unique skin aging pattern:** Photoaging presents differently — while fine wrinkling is delayed relative to lighter skin types, hyperpigmentation, uneven tone, and dermal changes (particularly dyschromia) are the primary aging concerns, not fine lines.

The American Academy of Dermatology has explicitly acknowledged that people with skin of color face "unique dermatologic concerns" and that "everyone regardless of skin tone should use sun protection" while also noting the specific challenge of conditions like PIH, melasma, and conditions that are more common or more severe in darker skin tones.

---

## The Primary Concern: Post-Inflammatory Hyperpigmentation

PIH is the dark macule left after any skin inflammation resolves — a pimple, an ingrown hair, eczema, a cut, an allergic reaction, even an overly aggressive skincare product. In darker skin, this process is more intense: the higher density and reactivity of melanocytes means more melanin is produced in response to the same inflammatory signal, and the deeper melanin placement in the dermis (dermal PIH) makes it more persistent and harder to treat.

**What makes PIH worse:**
- Picking, squeezing, or traumatizing lesions
- Harsh physical scrubs and over-exfoliation
- High-percentage AHAs used too frequently
- Irritating skincare actives that trigger reactive inflammation
- Sun exposure without SPF (UV stimulates melanocytes directly and worsens any existing PIH)

**The clinical result:** A single acne papule that would leave no mark in Fitzpatrick I–II skin may leave a dark mark lasting 6–18 months in Fitzpatrick V–VI skin. The prevention of inflammation is as important as the treatment of hyperpigmentation.

---

## Sunscreen: More Important Than You Think for Darker Skin Tones

A common and harmful myth is that people with darker skin don't need sunscreen. The facts:

- Light skin (Fitzpatrick I–III) has a natural SPF of approximately **3.3**
- Darker skin (Fitzpatrick IV–VI) has a natural SPF of approximately **13.4**

An SPF of 13.4 means approximately 7% of UV radiation passes through unattenuated — enough to drive melanocyte stimulation, worsen hyperpigmentation, and contribute to photoaging and skin cancer risk. The higher baseline melanin provides photoprotection but not immunity.

**Why SPF matters specifically for skin of color:**
1. **PIH amplification:** UV radiation stimulates melanocytes and darkens any existing PIH — wearing SPF is the most effective single habit for preventing PIH from worsening
2. **Melasma:** One of the most common hyperpigmentation conditions in skin of color is exquisitely UV-sensitive; SPF is mandatory for any treatment to work
3. **Skin cancer risk in darker skin:** Melanoma in skin of color is rarer but diagnosed later — often at more advanced stages — due to the myth that darker skin is not susceptible. The AAD is explicit: everyone should wear sunscreen and undergo regular skin checks

**For skin of color, sunscreen choice matters:**
- **Tinted mineral sunscreens with iron oxides** are strongly preferred. Iron oxides absorb visible light (blue-violet wavelengths ~415–450nm), which independently stimulates melanin production. A study demonstrated that a tinted SPF with iron oxides is more effective for melasma than untinted SPF at the same UV-protection level.
- **Cosmetic acceptability:** Chemical sunscreens (without physical filters) are often preferred by people with darker skin for their transparent finish and no white cast. Hybrid formulas (chemical + mineral) offer a middle ground.
- **Minimum:** SPF 30, broad-spectrum; SPF 50 preferred for outdoor use or melasma management

---

## Building a Routine for Skin of Color

### The Core Routine

**Step 1: Gentle, low-pH cleanser**
Avoid harsh cleansers with high sulfate content. For skin of color, inflammation from over-stripping the barrier is a direct pathway to PIH. A non-stripping, pH-balanced (5–6) gentle cleanser is the foundation.

**Step 2: Targeted active for hyperpigmentation (morning or evening — see below)**
Discussed in detail in the next section.

**Step 3: Moisturizer — non-comedogenic and fragrance-free**
A robust moisturizer maintains the barrier between the skin and potential inflammatory triggers. For oily skin, a gel or water-cream; for dry skin, a richer ceramide-containing cream. Fragrance is a leading cause of contact dermatitis and allergic sensitization — avoid it in all products.

**Step 4: SPF 30+ tinted mineral (morning only)**
As described above — tinted with iron oxides for enhanced visible-light protection.

---

## Evidence-Backed Depigmenting Agents

### Azelaic Acid (15–20%)

Azelaic acid is one of the strongest evidence-backed options for PIH and melasma in skin of color. It works by selectively inhibiting abnormally active melanocytes (sparing normal melanocyte function) while also providing anti-inflammatory and comedolytic benefits. A PMC systematic review on treatment of PIH in skin of color confirmed azelaic acid as a well-tolerated first-line topical option. Its selectivity for hyperactive melanocytes makes it particularly appropriate for skin of color, where nonselective agents risk unintended lightening of normal skin.

### Niacinamide (5–10%)

Niacinamide reduces hyperpigmentation by blocking the transfer of melanosomes from melanocytes to keratinocytes — a distinct mechanism from tyrosinase inhibition. A 2021 PMC review confirmed that topical niacinamide and the combination of niacinamide plus tranexamic acid significantly reduces pigmentation in clinical trials. Niacinamide also strengthens the skin barrier, controls sebum production, and reduces inflammation — all relevant for the PIH-prone skin of color patient. It is one of the safest and best-tolerated hyperpigmentation actives across all Fitzpatrick types.

### Tranexamic Acid (2–5%)

Tranexamic acid (TXA) is a lysine derivative that blocks the interaction between keratinocytes and melanocytes that activates melanin production after UV exposure or inflammation. A PMC systematic review on PIH prevention confirmed TXA as an emerging evidence-backed option with a good tolerability profile. Particularly effective for melasma when combined with niacinamide. Topical concentrations of 2–5% are used in cosmetic formulas; higher concentrations are available by prescription.

### Retinoids (Low Concentration)

Low-concentration retinol (0.025–0.1%) has important caveats for skin of color. Retinoids are effective for PIH by accelerating cell turnover and dispersing melanin granules. However, irritation from retinoids triggers reactive inflammation in skin of color — which then causes more PIH. This means:
- **Start lower and slower than with fair skin:** 0.025% maximum starting concentration
- **Build more gradually:** 2–3 times per week for 8–12 weeks before increasing frequency
- **Use the sandwich method:** Moisturizer before and after retinol to buffer irritation
- **Stop immediately if persistent redness develops:** The reactive melanocyte response to inflammation can worsen PIH within days

When tolerated well, retinoids are highly effective at gradually fading PIH and preventing new lesions.

### Hydroquinone (2%–4%)

Hydroquinone inhibits tyrosinase and is one of the most potent topical depigmenting agents available. It is FDA-approved at 2% OTC and 4% by prescription. It is effective for PIH and melasma in skin of color. However:
- Long-term use (>3–4 months continuously) without medical supervision risks **exogenous ochronosis** — a paradoxical darkening, particularly in skin of color from sub-Saharan Africa where certain cosmetic hydroquinone products have been heavily used
- Dermatologists typically recommend cyclic use (3 months on, then transition to maintenance with azelaic acid or niacinamide)
- Contraindicated in pregnancy

For those seeking medical-grade depigmentation, a dermatologist-supervised hydroquinone protocol combined with retinoid and SPF (the Kligman formula — hydroquinone 4% + tretinoin + mild steroid) remains the most robust evidence-backed approach for stubborn PIH.

### Vitamin C (10–15%)

Vitamin C inhibits tyrosinase and provides antioxidant protection against UV-triggered melanin synthesis. Its instability in formulation makes product choice important — look for L-ascorbic acid in opaque, dark packaging at a pH below 3.5, or a stable derivative (sodium ascorbyl phosphate, ascorbyl glucoside) if pure ascorbic acid causes sensitivity. Vitamin C is particularly effective as a morning preventive active — best combined with SPF.

### Kojic Acid and Glycolic Acid

Kojic acid (tyrosinase inhibitor, 1–2%) and glycolic acid (cell turnover acceleration, 5–10%) are additional evidence-backed options but have more potential for irritation. Glycolic acid at concentrations above 10% is inadvisable for home use in skin of color without dermatologist guidance — the exfoliant-induced inflammation risk is real.

---

## Specific Conditions More Common in Skin of Color

### Melasma

Melasma — patches of symmetrical, darkened pigmentation on the face — occurs across skin types but is significantly more prevalent in people with darker skin and in those with significant UV exposure history. It is estrogen-sensitive (exacerbated by pregnancy, oral contraceptives) and UV-driven. Management requires:
- Consistent daily SPF with iron oxides (non-negotiable)
- Azelaic acid, niacinamide, and/or tranexamic acid as core actives
- Retinoids to support cell turnover and melanin dispersal
- Physician-supervised hydroquinone for moderate-to-severe cases
- Avoiding triggers: heat, UV, hormonal contraceptives in severe cases

### Pseudofolliculitis Barbae (Razor Bumps)

Extremely common in Black men. Curved hair follicles cause hairs to re-enter the skin after shaving, triggering chronic inflammation and significant PIH. Management: use a single-blade razor or trimmer (not multi-blade), shave with the grain, use a salicylic acid or glycolic acid product after shaving to prevent keratinous plugging, apply azelaic acid or niacinamide to manage pigmentation.

### Eczema (Atopic Dermatitis) and PIH

Eczema is both more common and phenotypically different in skin of color: it presents more often as follicular, perifollicular, or lichenoid patterns rather than the classic eczematous plaques described in lighter-skin-based textbooks. Post-eczema PIH is significant. Management focuses on aggressive barrier repair (ceramide-based moisturizers, emollients), identification and elimination of triggers, and rapid treatment of flares to minimize PIH.

---

## Building Your Full Routine: A Practical Framework

### Morning
1. Gentle pH-balanced cleanser
2. Vitamin C serum (10–15%) — or niacinamide (5–10%) if vitamin C causes sensitivity
3. Tranexamic acid serum (2–5%) if melasma or PIH is active (optional — can alternate with vitamin C)
4. Light, non-comedogenic moisturizer (ceramides preferred)
5. Tinted SPF 30+ with iron oxides

### Evening
1. Gentle cleanser (double cleanse if wearing SPF and/or makeup)
2. Azelaic acid (10–20%) OR niacinamide serum (if not used in AM) — primary depigmenting step
3. Low-concentration retinol (0.025–0.05%) — on 2–3 alternating nights; on other nights, niacinamide or the azelaic acid step continues
4. Moisturizer (ceramide-containing; slightly richer than AM)

### What to Avoid
- Physical scrubs with beads or rough particles (inflammation risk → PIH)
- High-percentage peels at home (>10% glycolic, >2% salicylic leave-on)
- Fragrance in any leave-on product
- Benzoyl peroxide at high concentrations on large areas (causes transient bleaching in dark fabrics and some hypopigmentation risk at high concentrations in dark skin)
- Skipping SPF on the basis that darker skin "doesn't need it"

---

## When to See a Dermatologist

Skin of color patients should see a dermatologist for:
- Melasma that is not responding to 12 weeks of consistent OTC treatment
- PIH that persists beyond 12 months despite sun protection and active treatment
- Suspected ochronosis from long-term OTC hydroquinone use
- New dark patches that are irregular in shape or rapidly changing (rule out lentigo maligna)
- Eczema or psoriasis (both have different presentations in skin of color and often require different management than standard textbook descriptions)
- Annual skin checks (particularly for acral melanoma, which is disproportionately represented in darker skin tones and often diagnosed late)

A dermatologist who specializes in skin of color will have specific training in recognizing and treating conditions across all Fitzpatrick phototypes. The Society for Investigative Dermatology, AAD, and PCDS have all called for greater representation of skin of color in clinical research.

## FAQ
**What does the current evidence say about skincare for skin of color in 2026?**

The evidence base continues to grow, though it has historically underrepresented skin of color in clinical trials. Current systematic reviews (PMC, 2024) confirm azelaic acid, niacinamide, tranexamic acid, retinoids, and hydroquinone as the most evidence-backed topical options for PIH and melasma in darker skin tones. The AAD explicitly states that people with skin of color face unique dermatologic concerns and that sun protection is essential for all skin tones. The main evidence gaps are in laser and procedural interventions, where risk of PIH in darker skin types is higher and RCT data is less robust than for lighter skin types.

**Do people with darker skin need sunscreen?**

Yes — unequivocally. The higher natural SPF (approximately 13.4 versus 3.3 in fair skin) does not eliminate UV-driven melanocyte stimulation, hyperpigmentation risk, or skin cancer risk. UV exposure is the primary trigger that worsens existing PIH, drives melasma, and contributes to photoaging in darker skin tones. Additionally, melanoma in skin of color is often diagnosed at a later stage due to the misconception that it does not occur, making prevention and early detection more critical, not less. Daily SPF 30+ is a clinical recommendation for all Fitzpatrick types.

**What is the best ingredient for dark spots and hyperpigmentation in skin of color?**

No single ingredient is universally best — the most effective approach is combination therapy, because PIH and melasma involve multiple biological pathways. Azelaic acid 15–20% selectively inhibits overactive melanocytes with minimal normal-skin lightening. Niacinamide 5–10% blocks melanosome transfer. Tranexamic acid 2–5% interrupts UV-triggered melanocyte signaling. Vitamin C inhibits tyrosinase. Low-concentration retinoids accelerate melanin dispersal via cell turnover. SPF prevents all of these from being undermined by daily UV exposure. For stubborn hyperpigmentation, a dermatologist-supervised hydroquinone protocol is the most potent option.

**Is it safe to use retinol on darker skin?**

Yes, but with more caution than on lighter skin. The benefit (PIH fading, cell turnover, melanin dispersal) is real and clinically confirmed. The risk is that retinol-induced irritation in skin of color triggers reactive melanocyte inflammation, which can worsen PIH rather than improve it. Start at the lowest available concentration (0.025%), use only 1–2 times per week initially, use the sandwich method (moisturizer before and after), and stop immediately if persistent redness or worsening dark marks develop. Building very slowly over 12 weeks is the standard approach.

**Why does skin of color seem to handle aging differently than lighter skin?**

Several biological factors contribute. Higher melanin content provides greater protection against UV-induced collagen breakdown, delaying the fine-line wrinkling that characterizes photoaging in lighter skin types. However, deeper melanin storage in the dermis means dyschromia (uneven pigmentation) becomes the dominant aging marker earlier. Additionally, the connective tissue architecture and collagen density in darker skin types differ structurally — supporting facial volume longer. The trade-off is that while dark skin appears younger for longer in terms of wrinkles, it shows aging primarily through pigmentation irregularity and deeper nasolabial/melolabial changes rather than surface texture changes.

**Are chemical sunscreens safe to use on skin of color?**

Chemical sunscreens (oxybenzone, avobenzone, homosalate) are generally safe for skin use in skin of color in terms of irritation risk — they are often preferred because they leave no white cast. However, they do not block visible light (blue-violet wavelengths ~415–450nm), which independently triggers hyperpigmentation in melanin-rich skin. For active PIH or melasma, a tinted mineral SPF with iron oxides is clinically superior regardless of SPF number. For daily use without active pigmentation concerns, a chemical formula with good UV coverage is acceptable.

## Sources
- People with skin of color face unique dermatologic concerns — American Academy of Dermatology (AAD): https://www.aad.org/news/skin-of-color
- Treatment of Post-Inflammatory Hyperpigmentation in Skin of Color: A Systematic Review — PubMed Central / NCBI (2024-01-01): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514325/
- Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color: A Systematic Review — PubMed / International Journal of Dermatology (2025-01-01): https://pubmed.ncbi.nlm.nih.gov/39953770/
- Mechanistic Basis and Clinical Evidence for the Applications of Nicotinamide (Niacinamide) to Control Skin Aging and Pigmentation — PubMed Central / Antioxidants (MDPI) (2021-08-01): https://pmc.ncbi.nlm.nih.gov/articles/PMC8389214/
- Skin cancers in skin types IV–VI: Does the Fitzpatrick scale give a false sense of security? — PubMed Central / NCBI (2022-01-01): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060139/
- Prevention and Treatment of Skin Pigmentation Disorders — PubMed Central / NCBI (2024-01-01): https://pmc.ncbi.nlm.nih.gov/articles/PMC11313539/

_Health information, not medical advice._